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Abstract: The green alga Klebsormidium flaccidum var. zivo is a rich source of proteins, polyphenols,
and bioactive small-molecule compounds. An approach involving chromatographic fractionation,
anti-inflammatory activity testing, ultrahigh performance liquid chromatography-mass spectrometry
profiling, chemometric analysis, and subsequent MS-oriented isolation was employed to rapidly
identify its small-molecule anti-inflammatory compounds including hydroxylated fatty acids,
chlorophyll-derived pheophorbides, carotenoids, and glycoglycerolipids. Pheophorbide a, which
decreased intracellular nitric oxide production by inhibiting inducible nitric oxide synthase, was
the most potent compound identified with an IC50 value of 0.24 µM in lipopolysaccharides-induced
macrophages. It also inhibited nuclear factor kappaB activation with an IC50 value of 32.1 µM in
phorbol 12-myristate 13-acetate-induced chondrocytes. Compared to conventional bioassay-guided
fractionation, this approach is more efficient for rapid identification of multiple chemical classes of
bioactive compounds from a complex natural product mixture.
Keywords: Klebsormidium flaccidum var. zivo; Klebsormidiaceae; anti-inflammatory; iNOS;
NF-κB; chemometrics
1. Introduction
Classical approaches for identification of bioactive compounds from complex natural products
involve time-consuming, multi-step bioassay-guided isolation procedures [1,2]. Without appropriate
chemical and biological detection methods, often times bioactive compounds may be lost during
the isolation process. Over the past decade, however, the application of advanced analytical
and chromatographic instrumentation represented by hyphenated techniques such as LC-MS and
LC-MS-NMR has greatly improved the efficiency of bioactive natural products discovery [2–4].
In addition, data analysis tools utilized in metabolomics and chemometrics have efficiently facilitated
the identification of robust chemical markers for differentiation of plant species [5], screening of active
compounds [6], and searching for appropriate chemical markers for quality control [7].
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Klebsormidium (Klebsormidiaceae) is a genus of filamentous green algae distributed in terrestrial
habitats worldwide [8]. Little is known about the chemistry of the entire genus except for a report on
the analysis of fatty acids [9]. Klebsormidium flaccidum var. zivo is an optimized, non-GMO (genetically
modified organism), proprietary algal strain that produces a unique blend of proteins, polyphenols,
and small molecules [10]. The dried algal biomass of K. flaccidum var. zivo has been registered as
KALGAETM; and a 90-day dietary toxicity study of KALGAETM in CRL Sprague-Dawley CD IGS rats
and a genotoxicity evaluation in Swiss albino mice did not show adverse effects, supporting its safe use
as a potential food ingredient to improve human health [10]. However, its small-molecule metabolites
associated with biological activities remain unknown. Using an approach involving chromatographic
fractionation, anti-inflammatory activity testing, UHPLC-qMS profiling, chemometric analysis, and
selective isolation and purification, four chemotypes of compounds including hydroxylated fatty acids,
chlorophyll-derived pheophorbides, carotenoids, and glycoglycerolipids, were identified to contribute
to the anti-inflammatory activity of this alga. This study highlights the utility of a chemometrics-assisted
approach involving orthogonal partial least squares discriminant analysis (OPLS-DA) that can facilitate
rapid identification of multiple bioactive compounds from a complex natural product mixture.
2. Results and Discussion
2.1. Anti-Inflammatory Activities of Extracts and Column Fractions
To identify anti-inflammatory compounds from the algal biomass of K. flaccidum var. zivo, different
extracts using organic solvents and water were prepared to obtain chemical constituents across a
wide polarity range. Anti-inflammatory activity of extract was determined in terms of the decrease
of inducible nitric oxide (NO) production through inhibition of nitric oxide synthase (iNOS) in
lipopolysaccharides (LPS)-induced macrophages (RAW 264.7) and inhibition of nuclear factor kappaB
(NF-κB) activation in phorbol 12-myristate 13-acetate (PMA)-induced human chondrosarcoma cells
(SW1353) [11]. Preliminary testing results showed that the ethyl acetate extract exhibited highest
inhibitory activity in the aforementioned two cell models, indicating that the anti-inflammatory
constituents present in this alga are relatively lipophilic small-molecule compounds.
An ethyl acetate extract (IC50 28.0 µg/mL for iNOS) was thus fractionated into 21 fractions,
with increasing polarity from Fr. 1 to Fr. 21, by normal-phase column chromatography (Table S1 in
Supplemental Material). Assay for the inhibition of iNOS was used to monitor the anti-inflammatory
activity of all 21 fractions. As shown in Figure 1A, the activity is distributed across multiple fractions,
indicating the presence of multiple compounds contributing to the activity. The most active column
fraction (Fr.10) gave an IC50 value of 1.7 µg/mL compared against the IC50 value of 0.2 µg/mL of the
positive control parthenolide, suggesting potent anti-inflammatory compounds are present in the
algal biomass.
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Figure 1. (A) Anti-inflammatory activities of 21 column fractions derived from K. flaccidum var. zivo 
against iNOS, in comparison with the parent ethyl acetate extract and the positive control 
parthenolide; (B) Orthogonal partial least squares discriminant analysis (OPLS-DA) discriminating 
active and inactive fractions; and (C) UHPLC-qMS profiling of the ethyl acetate extract and its 21 
column fractions with compound numbers labeled beside respective peaks. 
2.2. Chemical Profiling of Small-Molecule Compounds by UHPLC-qMS-DAD 
Reversed-phase ultrahigh performance liquid chromatography (UHPLC) coupled with a single 
quadrupole mass spectrometer (qMS) and a multi-channel UV detector was utilized to generate 
chemical profiles of the 21 fractions derived from the ethyl acetate extract with the understanding 
that the response of different classes of compounds vary considerably under different MS detection 
methods. Taking advantage of qMS that operates in both positive and negative ionization mode (both 
ESI and APCI) simultaneously in a single run that facilitates identification of true molecular ion for a 
specific compound, four classes of compounds, including 21 fatty acid derivatives (1–10, 12–17, and 
20–24), seven pheophorbides (11, 26–28, 33, 39, and 42), five carotenoids (18, 19, 25, 29, and 30), and 
nine glycoglycerolipids (31, 32, 34–38, 40, and 41), were detected (Table 1, Figure 1C)[12–16]. A rapid 
structural identification or prediction of these compounds was conducted as follows. 
Figure 1. (A) Anti-infla atory activities of 21 colu n fractions derived fro K. flaccidum var. zivo
against iNOS, in comparison with the parent ethyl acetate extract and the positive control parthenolide;
(B) Orthogonal partial least squares discriminant analysis (OPLS-DA) discriminating active and inactive
fractions; and (C) UHPLC-qMS profiling of the ethyl acetate extract and its 21 column fractions with
compound numbers labeled beside respective peaks.
2.2. Chemical Profiling of Small-Molecule Compounds by UHPLC-qMS-DAD
Reversed-phase ultrahigh performance liquid chromatography (UHPLC) coupled with a single
quadrupole mass spectrometer (qMS) and a multi-channel UV detector was utilized to generate
chemical profiles of the 21 fractions derived from the ethyl acetate extract with the understanding
that the response of different classes of compounds vary considerably under different MS detection
methods. Taking advantage of qMS that operates in both positive and negative ionization mode
(both ESI and APCI) simultaneously in a single run that facilitates identification of true molecular
ion for a specific compound, four classes of compounds, including 21 fatty acid derivatives (1–10,
12–17, and 20–24), seven pheophorbides (11, 26–28, 33, 39, and 42), five carotenoids (18, 19, 25, 29, and
30), and nine glycoglycerolipids (31, 32, 34–38, 40, and 41), were detected (Table 1, Figure 1C) [12–16].
A rapid structural identification or prediction of these compounds was conducted as follows.
Table 1. Compounds 1–42 detected by UHPLC-qMS-UV in column fractions.
Compound m/z (+) a m/z (-) b RT c (min) UVmax (nm) Location d Identification/Prediction Reference
1 251 295 13.18 \ Fr. 2 7, 10, 13-Hexadecatrienoic acid e [12]
2 279 323 15.92 \ Fr. 2,3,4,5 α-Linolenic acid e [13]
3 305 349 17.60 \ Fr. 2 8, 11, 14-Eicosadienoic acid e [12]
4 281 325 17.98 \ Fr. 2 -Linoleic acid e [12]
5 277 293 11.77 \ Fr. 4,5 Hydroxy-C18:3 FA f
6 279 295 13.16 \ Fr. 4,5 Hydroxy-C18:2 FA f
7 281 301 14.96 \ Fr. 4 Hydroxy-C18:1 FA f
8 283 299 19.74 \ Fr. 4 Hydroxy-C18:0 FA f
9 305 321 9.67 \ Fr. 6 Hydroxy-C20:3 FA f
10 307 323 10.83 \ Fr. 6 Hydroxy-C20:2 FA f
11 607 605 22.51 408 Fr. 6 Pheophorbide a methyl ester [14]
12 293 309 10.47 \ Fr. 7 Dihydroxy-C18:3 FA f
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Table 1. Cont.
Compound m/z (+) a m/z (-) b RT c (min) UVmax (nm) Location d Identification/Prediction Reference
13 293 309 10.71 \ Fr. 7 Dihydroxy-C18:3 FA f
14 295 311 11.78 \ Fr. 7 Dihydroxy-C18:2 FA f
15 295 311 11.98 \ Fr. 7 Dihydroxy-C18:2 FA f
16 295 311 12.16 \ Fr. 7 Dihydroxy-C18:2 FA f
17 295 311 12.42 \ Fr. 7 Dihydroxy-C18:2 FA f
18 568 \ 22.95 454; 478 Fr. 6,7 Zeaxanthin [15]
19 568 \ 23.18 448; 474 Fr. 6,7 Lutein [15]
20 277 293 9.71 \ Fr. 8,9 Hydroxy-C18:3 FA f
21 277 293 9.92 \ Fr. 8 (10E,12Z,15Z)-9-hydroxyoctadecadienoic acid [16]
22 279 295 11.05 \ Fr. 8,9 (10E,12Z)-9-hydroxyoctadecadienoic acid [16]
23 278 \ 13.12 \ Fr. 8 C18:3 FAA g
24 280 \ 14.98 \ Fr. 8 (9Z,12Z)-octadecadienamide [17]
25 584 h \ 17.59 448; 474 Fr. 8,9 Capsanthin [18]
26 593 591 19.36 410 Fr. 9,10,11 Pheophorbide a [19]
27 593 591 20.32 410 Fr. 9,10,11 15-Epimer of Pheophorbide a [19]
28 607 605 15.86 436 Fr. 10 Pheophorbide b [14]
29 600 h \ 16.55 438; 466 Fr. 11,12 Neoxanthin [15]
30 600 h \ 17.00 440; 471 Fr. 11,12 Violaxanthin [15]
31 767 789 23.29 \ Fr. 12,13 MGDG i(16:4/18:3) [20]
32 769 791 24.85 \ Fr. 12 MGDG (16:3/18:3) [21]
33 609 607 17.64 408 Fr. 13 15-Hydroxy-pheophorbide a j [14]
34 507 529 6.99 \ Fr. 17 MGMG k (C16:4) [22]
35 509 531 7.66 \ Fr. 17 MGMG (C16:3) [23]
36 511 533 8.96 \ Fr. 17 MGMG (C16:2) [23]
37 537 559 9.86 \ Fr. 17 MGMG (C18:3) [24]
38 539 561 11.24 \ Fr. 17 MGMG (C18:2)
39 609 607 18.50 408 Fr. 17,18 15-Hydroxy-pheophorbide a j [14]
40 929 951 19.90 \ Fr. 18 DGDG l(16:4/18:3) [12]
41 931 953 20.89 \ Fr. 18 DGDG (16:3/18:3) [12]
42 625 623 17.99 400 Fr. 19,20 Hydro-pheophorbide-lactone a [25]
a Precursor ion in ESI (+); 1, 2, 3, 4, 11, 24, 26, 27, 28, 33, 39, 42 exhibit [M + H]+ in ESI (+); 5, 6, 7, 8, 9, 10, 12, 13, 14, 15,
16, 17, 20, 21, 22, 23, 24 exhibit [M − H2O + H]+ in ESI (+); 31, 32, 34, 35, 36, 37, 40, 41 exhibit [M + Na]+ in ESI (+). b
Precursor ion in ESI (−); 1, 2, 3, 4, 31, 32, 34, 35, 36, 37, 40, 41 exhibit [M + HCOO]− in ESI (+); 5, 6, 7, 8, 9, 10, 11, 12, 13,
14, 15, 16, 17, 20, 21, 22, 26, 27, 28, 33, 39, 42 exhibit [M − H]− in ESI (+). c Retention time. d Column fraction(s) in which
compounds are located. e Identification was confirmed by GC-MS analysis. f Fatty acid. g Fatty acid amide. h Compound
forming a radical molecular ion [M]+. i Monogalactosyldiacylglycerol. j 33 and 39 were identified as diastereoisomers. k
Monogalactosylmonoacylglycerol. l Digalactosyldiacylglycerol.
The presence of fatty acids in Klebsormidium spp. [9] prompted a dereplication analysis of such
compounds in K. flaccidum var. zivo. Typical chromatographic behaviors of major compounds in Fr.1−9
and their precursor ions identified from ESI-MS spectra were clearly associated with fatty acids or their
derivatives. Generally, fatty acids are better ionized in negative ESI mode [26]. Hydroxylated fatty
acids show de-protonated quasi-molecular ion [M − H]− and de-hydrated protonated quasi-molecular
ion [M + H − H2O]+ in the ESI (−) and ESI (+) MS spectra, respectively. Dihydroxylated fatty
acids may produce a fragment ion at m/z [M + H − 2H2O]+ (see Figure S1). Four fatty acids,
7,10,13-hexadecatrienoic acid (1), α-linolenic acid (2), 8, 11, 14-eicosadienoic acid (3), and linoleic acid
(4), which are present in the least polar Fr. 1 and Fr. 2 were readily determined by the LC-MS data. This
was further confirmed by orthogonal GC-MS analysis, which characterized the four compounds and
additional non-hydroxylated fatty acids that were not detected by LC-MS (see Table S2 and Figure S2).
The remaining 14 hydroxylated fatty acids or their derivatives were characterized at structural type
only because LC-MS cannot provide exact structural information of such compounds in terms of
positional and configurational double bonds and hydroxyl groups.
The strong green color of this algal material certainly suggests the presence of chlorophyll-derived
compounds. Analysis of the ESI-MS and UV data of the dominant peaks in Fr. 9−11 indicated
that pheophorbide a (26) and epi-pheophorbide a (27) [27] were present in these fractions (Table 1),
which was further confirmed by direct comparison of LC-MS-UV data with an authentic sample of
pheophorbide a. Partial conversion of 26 into 27 was observed to occur in solution (e.g., methanol)
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stored at room temperature for a couple of days due to inherent structural tautomerism. Compounds
26 and 27 (m/z 593 [M + H]+) are characteristic for a strong UV absorption around 410 nm [14].
Additional five analogues with similar UV characteristics were identified in Fr. 6, Fr. 10, Fr. 13, Fr.
17/18, and Fr. 19/20 (Table 1, Figure 1C). Based on their mass data and chromatographic behaviors
associated with polarity and retention time, the five compounds were predicted to be pheophorbide
a methyl ester (11) [14], pheophorbide b (28) [14], hydroxyl-pheophorbide a (33) [14], isomer of
hydroxyl-pheophorbide a (39) [14], and hydro-pheophorbide-lactone a (42) [25].
Analysis of the compounds with retention time around 23 min (Figure 1C) and characteristic UV
absorptions at 430−480 nm in Fr. 6/7 (Table 1) suggested a chemical skeleton for carotenoids as such
compounds were previously identified in several algal materials [28]. Lutein (19) was unequivocally
determined to be present in Fr. 6/7 by direct comparison of LC-MS-UV data with an authentic sample.
Zeaxanthin (18), a structural isomer of lutein, was also readily identified in Fr. 6/7 by comparison of
their UV absorptions in which zeaxanthin has relatively longer UV wavelengths (Table 1, Figure S3)
due to an extended conjugated system [15]. The presence of three additional carotenoids, capsanthin
(25) in Fr. 8/9, and neoxanthin (29) and violaxanthin (30) in Fr. 11/12, whose structures are closely
related to lutein and zeaxanthin, were indicated by their characteristic UV absorptions and molecular
weight information (Table 1) [15,18].
Glycoglycerolipids are major components of chloroplast lipids in algae [29]. Our LC-MS
data showed the presence of two monogalactosyldiacyglycerols (MGDGs) (31 [20] and 32 [21])
in Fr. 12/13, five monogalactosylmonoacyglycerols (MGMGs) (34–38) [22–24] in Fr. 17, and two
digalactosyldiacylglycerols (DGDGs) (40 and 41) [12] in Fr. 18. All these galactolipids formed sodium
adduct ions [M + Na]+ and formate adduct ions [M + HCOO]− in the positive and negative ESI-MS
spectra, respectively. In the positive ESI-MS spectra, the fragment ion [M + H – 162 (hexose)]+
corresponding to the loss of a galactosyl moiety was observed in MGDGs and MGMGs, while the
fragment ion [M + H – 162 × 2]+ corresponding to the loss of two galactosyl units were commonly
present in DGDGs. For MGDGs and DGDGs, fragment ions corresponding to individual acyl groups,
e.g., in compound 31, were observed as well (Figure S4).
2.3. Determination of Anti-Inflammatory Markers by Chemometric Analysis
Chemometrics was applied to explore potential anti-inflammatory marker compounds in all
21 column fractions, which were classified into two groups, active and inactive, according to IC50
values of iNOS inhibition. Twelve fractions (Fr. 5, Fr. 7–14, and Fr. 17–19) that had enriched
activities with IC50 values less than that of the parent ethyl acetate extract (28.0 µg/mL) were defined
as active, while the remaining nine fractions were considered as inactive (Figure 1A). For each
fraction, 654 chromatographic signals generated from the positive ESI-MS were used for OPLS-DA
modeling, which clearly showed discrimination of respective fractions in the active and inactive groups
(Figure 1B). Thirty-eight signals with variable importance in projection (VIP) values greater than 1.5
were shown from the S-plot (Figure 2A), and were defined as potential anti-inflammatory marker
signals. The coefficient plot (Figure S6) indicated that these signals correlated with eight compounds
shown in Figure 2B,C. It is interesting to note that the eight marker compounds derived from active
fractions represent the aforementioned four classes of compounds. According to the literature, iNOS
inhibitory activities of violaxanthin (30) (Marker A) [30], pheophorbide a (26) (Marker C) [19], and
MGDG-1 (31) (Marker H) [20] have been reported. Fatty acids, especially hydroxylated fatty acids,
have also demonstrated anti-inflammatory activity via multiple molecular mechanisms including
iNOS inhibition [31,32], supporting identification of compounds 21 (Marker B) and 16 (Marker F) as
anti-inflammatory markers. The remaining three marker compounds 27 (Marker D), 39 (Marker E),
and 33 (Marker G) are analogues of pheophorbide a, thereby implicating potential anti-inflammatory
activity as well.
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of chromatographic signals of 21 column fractions generated from the positive ESI-MS with 38 marker
signals (VIP > 1.5) highlighted in red; (B) VIP plot showing 8 marker compounds corresponding to
38 marker signals; and (C) chromatographic and MS information of the 8 marker compounds.
The anti-inflammatory data for all active fractions in terms of IC50 values for inhibition of iNOS
(as shown in Figure 1A) appear to support that pheophorbide a, the major compound in Fr. 9
and Fr. 10 (Figure 1C, Table S1), along with pheophorbide a analogues and another three classes
of compounds (fatty acids, carotenoids, and glycoglycerolipids) are responsible for much of the
anti-inflammatory activity of the extract. Thus, chemometrics is an excellent tool to rapidly predict
multiple anti-inflammatory compounds from a complex mixture.
2.4. Isolation and Anti-Inflammatory Testing of Purified Compounds
To validate the prediction of chemometric analysis, Fr. 8 containing fatty acid 21 [16], Fr. 10
containing pheophobide a (26), and Fr. 12 containing glycoglycerolipid 31 were selected for follow-up
isolation of representative anti-inflammatory marker compounds, followed by structural confirmation
and anti-inflammatory testing. This selection criterion was based on potent activity, significant quantity,
and unique chemical profiles of the active fractions. As a result, marker compounds 21, 26, and 31
representing hydroxylated fatty acids, chrolorophyll-derived pheophobides, and glycoglycerolipids,
respectively, were isolated, and their structures were confirmed by NMR spectroscopic analysis.
The carotenoid violaxanthin (29) (Marker A) is a minor compound in Fr. 11 based on the LC-MS-UV
profile and its anti-inflammatory activity has previously been reported [30]. Thus, isolation of this
compound from Fr. 11 with a relative low activity (IC50, 16.0 µg/mL) was not pursued.
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The evaluation of anti-inflammatory activity of the three purified marker compounds indicated
that pheophorbide a (26) was the most active in inhibiting iNOS with an IC50 value of 0.24 µM, while
(10E,12Z,15Z)-9-hydroxyoctadecadienoic acid (21) and MGDG-1 (31) were less active with IC50 values
of 22.4 and 17.4 µM, respectively (Table 2). Compounds 26, 21, and 31 also demonstrated moderate
inhibitory activity against NF-κB with IC50 values of 32.1, 122.3, and 47.0 µM, respectively. The NF-κB
inhibitory activity of 26 had previously been reported [33]. A commercial sample of lutein was also
tested, which gave an IC50 value of 26.4 µM against iNOS, but was not active against NF-kB (Table 2).
These activity data, in conjunction with chemical profiling and relative contents of potential active
compounds, explain well the IC50 values of relevant active column fractions (Figure 1, Table S1).
Considering the low potency of other active fractions, isolation of additional active compounds
from this algal material that outperform pheophorbide a in terms of iNOS inhibition is unlikely.
For example, we conducted isolation of hydro-pheophorbide-lactone a (42, Figure 3), a structurally
close pheophorbide a analogue, which was present in Fr. 19 with an IC50 value of 25.0 µg/mL for
structural confirmation because only partial NMR data of this compound has been available in the
literature [25]. This compound inhibited iNOS with an IC50 value of 20.8 µM which is approximately
87-fold less active than pheophorbide a. Thus, pheophorbide a is the most active among all identified
anti-inflammatory compounds.
Table 2. In vitro anti-inflammatory activities of compounds 19, 21, 26, and 31.
Compound iNOS (IC50, µM) NF-κB (IC50, µM)
19 a 26.4 ± 5.3 NA b
21 22.4 ± 2.4 122.3 ± 20.3
26 0.24 ± 0.03 132.1 ± 3.4
31 17.4 ± 1.3 47.0 ± 6.7
Parthenolide 0.72 ± 0.08 3.83 ± 0.60
a Obtained from a commercial source. b Not active at the highest test concentration of 87.9 µM (50 µg/mL).
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In conclusion, a chemometrics-assisted approach has demonstrated its advantage in rapidly
identifying anti-inflammatory compounds from K. flaccidum var. zivo with minimum isolation efforts.
Our findings may facilitate product development using an optimized algal biomass with high contents
of bioactive compounds. This approach can be utilized to accelerate the discovery of bioactive natural
products preferably with novel chemistry.
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3. Materials and Methods
3.1. General Experimental Procedures
The NMR spectra using standard pulse programs were recorded at room temperature on a Bruker
Avance DPX-400 spectrometer (Bruker, Billerica, MA, USA) operating at 400 (1H) and 100 (13C) MHz.
The chemical shift (δ, ppm) values were calibrated using the residual NMR solvent and coupling
constant (J) was reported in Hertz (Hz). Column chromatography was done on normal-phase silica
gel (230 × 400 mesh, J. T. Baker, Center Valley, PA, USA) or reversed-phase silica gel (C18, 40 µm, J. T.
Baker). Silica gel 60 F254 TLC plates (Merck, Darmstadt, Germany) and reversed-phase TLC plates (C18,
Merck, Darmstadt, Germany) were used for analytical TLC. The plates were visualized by spraying 10%
H2SO4 followed by heating. The authentic samples pheophorbide a (>95%) and lutein (>90%) were
purchased from Cayman Chemical Company (Ann Arbor, MI, USA) and Acros Organics (Pittsburgh,
PA, USA), respectively. Their structure and purity were further confirmed by NMR and HPLC in our
laboratory. The 37 standards of fatty acid methyl esters (Supelco®37 components FAME mix) used for
GC-MS analysis were purchased from Sigma-Aldrich (St. Louis, MO, USA).
3.2. Plant Material
The algal biomass KALGAETM is derived from K. flaccidum var. zivo and its general physical,
chemical, and nutritional compositions has been descried in a previous paper [10].
3.3. Extraction of Algal Biomass
In total, 10.0 g of powdered biomass was extracted with 200 mL of methanol under ultrasonication
(40 kHz, 300W) for 1 h, and allowed to stand overnight. The mixture was then filtered using a vacuum
suction filter to obtain the organic phase. A portion of organic phase (50 mL) was evaporated to dryness
to yield a methanol extract (0.41 g). The remaining 150 mL was evaporated to dryness, suspended
in 150 mL of water and extracted with an equal volume of ethyl acetate five times. The combined
ethyl acetate layers were concentrated to dryness to yield an ethyl acetate extract (0.36 g). Scale-up
extractions with same ratios of sample and solvent produced similar yields of extracts. To prepare the
water extract that may contain polysaccharides, 10.0 g of powdered biomass was extracted with 200 mL
of water under ultrasonication (40 kHz, 300W) for 1 h. The mixture was then filtered using a vacuum
suction filter to obtain the water phase, which was freeze dried to yield the desired extract (2.44 g).
3.4. Fractionation of Ethyl Acetate Extract
15.0 g of ethyl acetate extract, prepared from a scale-up extraction, was absorbed on normal-phase
silica gel and then loaded on a normal-phase silica gel column (200 g). The column was eluted with
chloroform first and then a gradient solvent system consisting of chloroform and methanol in ratios
of 100:1, 50:1, 20:1, 10:1, 5:1, 1:1. Based on the TLC analysis, fractions containing similar compounds
were combined to afford 21 major fractions (Fr.1−21). The detailed information on weight and solvent
systems used to generate fractions is shown in the Supplementary Material (Table S1).
3.5. Chemical Profiling of Column Fractions by UHPLC-qMS-DAD
An Agilent Series 1290 UHPLC system (Agilent Technologies, Santa Clara, CA, USA) coupled
with a DAD detector and an Agilent 6120 quadrupole-MS mass spectrometer were utilized for chemical
profiling. Column fractions were prepared at a concentration of 1 mg/mL in methanol. Separation was
achieved using an Agilent Eclipse Plus-C18 column (100 × 2.1 mm, 1.8 µm) maintained at 25 ◦C. Binary
mobile phase was 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B) at a flow rate
of 0.25 mL/min under the following gradient program: 0–6 min, 30–50% (B); 6–10 min, 50–80% (B);
10–23 min, 80–95% (B); 23–25 min, 95–100% (B). The UV wavelength detection was set as 254, 400,
410 and 450 nm with a bandwidth of 4. The spectrum was stored from 190 to 600 nm. MS data was
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obtained under the ESI (±) mode. Optimal source parameters were set as follows: drying gas (N2) flow
rate, 10.0 L/min; drying gas temperature, 300 ◦C; nebulizer, 35 psig; vaporizer temperature, 200 ◦C;
capillary voltage, 4.0 kV; fragmentor voltage, 100 V. Each sample was analyzed over the mass range of
m/z 100-1500. A QC sample was prepared using pooled column fractions and analyzed once every
three tested samples to monitor the system stability.
3.6. Chemometric Analysis
Raw UHPLC-qMS data of 21 column fractions acquired in the ESI (+) mode were processed by
Agilent ChemStation software (E.02.02) to export a data matrix containing retention times and peak
intensities into Excel, in which 654 signals of each fraction were included in the retention time window
between 5 and 25 min. This dataset was used as an input for SIMCA-P 13.0 to perform OPLS-DA.
The corresponding VIP values were calculated. According to the distribution of signals and VIP values,
the signals showing a VIP value > 1.5 were considered as potential marker signals. The marker signals
were then correlated with specific compounds based on the retention time and LC-qMS identification
of active compounds in column fractions.
3.7. Isolation of Anti-Inflammatory Marker Compounds from Active Column Fractions
Detailed procedures for the isolation of compounds 21, 22, and 24 from Fr. 8, 26 from Fr. 10, 31
from Fr. 12, and 42 from Fr. 19 are shown in Supplementary Material.
3.8. In Vitro Anti-Inflammatory Assays for Inhibition of iNOS and NF-κB
Extracts (20 mg/mL), fractions (20 mg/mL) and compounds (2 mg/mL) were dissolved in DMSO
and diluted in serum free media prior to the assay to achieve various test concentrations. The assays for
inhibition of iNOS and NF-κB activity were performed in mouse macrophage (RAW264.7) and human
chondrosarcoma (SW1353) cell lines, respectively. Both cell lines were obtained from American Type
Culture Collection (ATCC), Manassas, VA, USA. The detailed procedures have been described in a
previous publication [34]. IC50 values were obtained from concentration response curves. Parthenolide
was used as a positive control in the both assays.
Supplementary Materials: Supplementary materials, including isolation procedure for selected anti-inflammatory
compounds, GC-MS analysis of fatty acids, and NMR and MS spectra of isolated compounds are available online.
Author Contributions: S.Q.: chemical analysis, isolation, data analysis and manuscript preparation; S.I.K.,
bioassay and interpretation of data and manuscript editing; M.W., LC-MS analysis and manuscript editing; J.Z.,
NMR analysis and manuscript editing; S.R., chemical analysis and isolation; I.A.K., A.S., W.P.P., data analysis and
manuscript editing; X.-C.L., data analysis and manuscript preparation and revision. All authors have read and
agreed to the published version of the manuscript.
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